Tokyo, March 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060985) titled 'ZURZUVAE Capsules 30mg Drug Use-results Survey' on March 19.
Study Type:
Observational
Primary Sponsor:
Institute - Shionogi & Co., Ltd.
Condition:
Condition - Depression or Depressed State
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To collect the safety and the efficacy of ZURZUVAE Capsules under clinical practice
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patient with depression or depressed state who has not been treated with ZURZUVAE...